Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that Jeremy Levin, DPhil, MB, BChir, Chairman and Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020
February 25, 2020
· 1 min read